IL60599A0 - N-substituted 5-acylindane-2-carboxamides and salts thereof and pharmaceutical compositions containing them - Google Patents

N-substituted 5-acylindane-2-carboxamides and salts thereof and pharmaceutical compositions containing them

Info

Publication number
IL60599A0
IL60599A0 IL60599A IL6059980A IL60599A0 IL 60599 A0 IL60599 A0 IL 60599A0 IL 60599 A IL60599 A IL 60599A IL 6059980 A IL6059980 A IL 6059980A IL 60599 A0 IL60599 A0 IL 60599A0
Authority
IL
Israel
Prior art keywords
acylindane
carboxamides
salts
substituted
pharmaceutical compositions
Prior art date
Application number
IL60599A
Other languages
English (en)
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of IL60599A0 publication Critical patent/IL60599A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL60599A 1976-12-14 1980-07-15 N-substituted 5-acylindane-2-carboxamides and salts thereof and pharmaceutical compositions containing them IL60599A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7637574A FR2374032A2 (fr) 1976-12-14 1976-12-14 Nouveaux acides carboxyliques derives de l'indane

Publications (1)

Publication Number Publication Date
IL60599A0 true IL60599A0 (en) 1980-09-16

Family

ID=9181028

Family Applications (2)

Application Number Title Priority Date Filing Date
IL60599A IL60599A0 (en) 1976-12-14 1980-07-15 N-substituted 5-acylindane-2-carboxamides and salts thereof and pharmaceutical compositions containing them
IL60598A IL60598A0 (en) 1976-12-14 1980-07-15 Ester derivative of 5-acylindane-2-carboxylic acid and salts thereof and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL60598A IL60598A0 (en) 1976-12-14 1980-07-15 Ester derivative of 5-acylindane-2-carboxylic acid and salts thereof and pharmaceutical compositions containing them

Country Status (21)

Country Link
JP (1) JPS5373548A (fr)
AT (1) AT355559B (fr)
AU (1) AU515268B2 (fr)
BE (1) BE861826R (fr)
CA (1) CA1088554A (fr)
CH (1) CH627728A5 (fr)
DD (1) DD133323A6 (fr)
DE (1) DE2753315A1 (fr)
DK (1) DK144640C (fr)
ES (1) ES465056A2 (fr)
FR (1) FR2374032A2 (fr)
GB (1) GB1584298A (fr)
HU (1) HU177226B (fr)
IE (1) IE46013B1 (fr)
IL (2) IL60599A0 (fr)
MX (1) MX4954E (fr)
NL (1) NL7713876A (fr)
NO (1) NO774285L (fr)
SE (1) SE436740B (fr)
SU (1) SU799646A3 (fr)
ZA (1) ZA777438B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2801182A1 (fr) * 2010-06-16 2011-12-22 Metabolex, Inc. Agonistes du recepteur gpr120 et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4980053A (fr) * 1972-12-05 1974-08-02
JPS5838416B2 (ja) * 1974-05-31 1983-08-23 武田薬品工業株式会社 カンジヨウカゴウブツノセイゾウホウ
JPS5335944B2 (fr) * 1974-05-21 1978-09-29

Also Published As

Publication number Publication date
DE2753315A1 (de) 1978-06-15
DK554677A (da) 1978-06-15
NO774285L (no) 1978-06-15
AT355559B (de) 1980-03-10
FR2374032A2 (fr) 1978-07-13
IL60598A0 (en) 1980-09-16
MX4954E (es) 1983-01-13
GB1584298A (en) 1981-02-11
DD133323A6 (de) 1978-12-27
BE861826R (fr) 1978-06-14
DK144640B (da) 1982-04-26
ZA777438B (en) 1979-05-30
DK144640C (da) 1982-10-04
JPS5373548A (en) 1978-06-30
SE7714110L (sv) 1978-06-15
CA1088554A (fr) 1980-10-28
IE46013L (en) 1978-06-14
SE436740B (sv) 1985-01-21
AU515268B2 (en) 1981-03-26
SU799646A3 (ru) 1981-01-23
CH627728A5 (en) 1982-01-29
AU3153077A (en) 1979-06-21
IE46013B1 (en) 1983-01-26
NL7713876A (nl) 1978-06-16
HU177226B (en) 1981-08-28
ATA892577A (de) 1979-08-15
ES465056A2 (es) 1979-01-16
FR2374032B2 (fr) 1979-03-30

Similar Documents

Publication Publication Date Title
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
JPS54109963A (en) Amine derivatives* their manufacture and pharmaceutical composition containing them
NZ182011A (en) N- -haolethyl (or hydroxyethyl)-nortropine benzilates salts and pharmaceutical compositions
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ184263A (en) N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
IL53171A0 (en) N-substituted lactams their preparation and pharmaceutical compositions containing them
PH13392A (en) Thiourea derivatives and pharmaceutical compositions containing them
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
IL52409A0 (en) 5-m-tolyloxyuracil and pharmaceutical compositions containing it
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ184808A (en) Heterocyclic compounds and pharmaceutical compositions
JPS52156934A (en) Pharmaceutical composition containing piperadine derivative and salt thereof
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
AU506783B2 (en) Cyclic amides and pharmaceutical compositions containing them
NZ184367A (en) 2-vinyl-chromone derivatives and pharmaceutical compositions